Revenue growth, profitability and cashflow... and yet the worst valuation in mental health

a pharma market with a twist

Neurotech, Gen-AI, metabolic psychiatry and more...

How to understand market fundamentals to design better strategy in mental health

+ funding for novel target validation for mental health drug discovery

The bull case, bear case and my verdict on this deal